Cytotoxic metabolites from the endophytic fungus Penicillium chermesinum: discovery of a cysteine-targeted Michael acceptor as a pharmacophore for fragment-based drug discovery, bioconjugation and click reactions

被引:42
作者
Darsih, Cici [1 ]
Prachyawarakorn, Vilailak [2 ]
Wiyakrutta, Suthep [3 ]
Mahidol, Chulabhorn [1 ,2 ]
Ruchirawat, Somsak [1 ,2 ,4 ]
Kittakoop, Prasat [1 ,2 ,4 ]
机构
[1] Chulabhorn Grad Inst, Chem Biol Program, Bangkok 10210, Thailand
[2] Chulabhorn Res Inst, Bangkok 10210, Thailand
[3] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand
[4] Minist Educ, CHE, Ctr Excellence Environm Hlth & Toxicol EHT, Bangkok, Thailand
关键词
ALPHA; BETA-UNSATURATED CARBONYL-COMPOUNDS; IN-VITRO; HISTONE DEACETYLASE; THIOL-ENE; PR TOXIN; INHIBITORS; DESIGN; FUNCTIONALIZATION; GLUTATHIONE; MYCOTOXIN;
D O I
10.1039/c5ra13735g
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Fungal metabolites (1-8) including known compounds, TMC-264 (1), PR-toxin (6) and a sesquiterpene (7), and new natural products 2-5 and 8, were isolated from the mangrove endophytic fungus Penicillium chermesinum. Compound 2 was a novel tetracyclic polyketide uniquely spiro-attached with a g-lactone ring. Compounds 1 and 6 exhibited comparable cytotoxic activity to that of doxorubicin, and they selectively exhibited activity toward certain cancer cell lines. The cytotoxicity of 1 might be due to the beta-chloro substituted alpha,beta-unsaturated ketone functionality, which was reactive toward glutathione and peptides containing a thiol group. The polyketide 1 reacted with glutathione and peptides under physiological conditions, and its thiol-reactive pharmacophore is possibly applicable to the design of glutathione modulation agents, fragment-based drug discovery (for irreversible enzyme inhibitors), bioconjugation, and click reactions. Facile C-S bond formation in water (catalyst-free conditions) inspired by 1 could also be useful for green chemistry.
引用
收藏
页码:70595 / 70603
页数:9
相关论文
共 59 条
[21]   A Fragment-Based Method to Discover Irreversible Covalent Inhibitors of Cysteine Proteases [J].
Kathman, Stefan G. ;
Xu, Ziyang ;
Statsyuk, Alexander V. .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (11) :4969-4974
[22]   Benzylidene-linked thiohydantoin derivatives as inhibitors of tyrosinase and melanogenesis: importance of the β-phenyl-α,β-unsaturated carbonyl functionality [J].
Kim, Hye Rim ;
Lee, Hye Jin ;
Choi, Yeon Ja ;
Park, Yun Jung ;
Woo, Youngwoo ;
Kim, Seong Jin ;
Park, Min Hi ;
Lee, Hee Won ;
Chun, Pusoon ;
Chung, Hae Young ;
Moon, Hyung Ryong .
MEDCHEMCOMM, 2014, 5 (09) :1410-1417
[23]   Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis [J].
Krishnan, Shyam ;
Miller, Rand M. ;
Tian, Boxue ;
Mullins, R. Dyche ;
Jacobson, Matthew P. ;
Taunton, Jack .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2014, 136 (36) :12624-12630
[24]   Untapped mutualistic paradigms linking host plant and endophytic fungal production of similar bioactive secondary metabolites [J].
Kusari, Souvik ;
Pandey, Shree P. ;
Spiteller, Michael .
PHYTOCHEMISTRY, 2013, 91 :81-87
[25]  
Lin AQ, 2014, ARCH PHARM RES, V37, P839
[26]   Bioactive Metabolites from Mangrove Endophytic Fungus Aspergillus sp 16-5B [J].
Liu, Yayue ;
Chen, Senhua ;
Liu, Zhaoming ;
Lu, Yongjun ;
Xia, Guoping ;
Liu, Hongju ;
He, Lei ;
She, Zhigang .
MARINE DRUGS, 2015, 13 (05) :3091-3102
[27]   Synthesis of heteroaryl containing sulfides via enaminone ligand assisted, copper-catalyzed C-S coupling reactions of heteroaryl thiols and aryl halides [J].
Liu, Yunyun ;
Huang, Bin ;
Cao, Xiaoji ;
Wu, Dan ;
Wan, Jie-Ping .
RSC ADVANCES, 2014, 4 (71) :37733-37737
[28]   Drug discovery considerations in the development of covalent inhibitors [J].
Mah, Robert ;
Thomas, Jason R. ;
Shafer, Cynthia M. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (01) :33-39
[29]   Native Chemical Ligation,Thiol-Ene Click: A Methodology for the Synthesis of Functionalized Peptides [J].
Markey, Lyn ;
Giordani, Silvia ;
Scanlan, Eoin M. .
JOURNAL OF ORGANIC CHEMISTRY, 2013, 78 (09) :4270-4277
[30]   Dimethyl sulfoxide to vorinostat: Development of this histone deacetylase inhibitor as an anticancer drug [J].
Marks, Paul A. ;
Breslow, Ronald .
NATURE BIOTECHNOLOGY, 2007, 25 (01) :84-90